Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis

Brian Lipworth (Lead / Corresponding author), Rory Chan, Chris Kuo

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	413
Number of pages	1
Journal	Journal of Allergy and Clinical Immunology
Volume	147
Issue number	1
Early online date	5 Nov 2020
DOIs	https://doi.org/10.1016/j.jaci.2020.09.024
Publication status	Published - Jan 2021

ASJC Scopus subject areas

@article{105549ce2e50459593c8bef9ec26e403,

title = "Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis",

author = "Brian Lipworth and Rory Chan and Chris Kuo",

year = "2021",

month = jan,

doi = "10.1016/j.jaci.2020.09.024",

language = "English",

volume = "147",

pages = "413",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis

AU - Lipworth, Brian

AU - Chan, Rory

AU - Kuo, Chris

PY - 2021/1

Y1 - 2021/1

UR - http://www.scopus.com/inward/record.url?scp=85096615313&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2020.09.024

DO - 10.1016/j.jaci.2020.09.024

M3 - Letter

C2 - 33160644

SN - 0091-6749

VL - 147

SP - 413

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 1

ER -